NEWS DESK

IVZ Stock News, News Score & What It Could Mean

Invesco Ltd Common Stock (IVZ) is currently showing a bullish headline tone with a mixed / range backdrop. The latest news flow is being framed here as context rather than prediction, so beginners can quickly see whether headlines are helping, hurting, or complicating the chart story. Earnings tone is currently positive earnings tone.

HEADLINE TAKE: Higher-value headlines lean meaningfully positive, with stronger signals around growth, upgrades, guidance, or demand.
Change stock
Search another ticker to view its latest news page.
Full chart, indicators and drawing tools on TradingView. Move to Platforms when you are ready to act.
NEWS SCORE
75/100
Bullish
Bearish
Neutral
Bullish
Earnings Tone
55
Neutral based on actual EPS/revenue
Confidence
Medium
Headline depth
Last Price
$30.30
Trend Context
Mixed / range
Latest briefing

What's happening with IVZ

prnewswire.com15 Jul 2026

Invesco Mortgage Capital Inc. July 2026 Dividend Announcement and June Financial Update

ATLANTA, July 15, 2026 /PRNewswire/ -- Invesco Mortgage Capital Inc. (NYSE: IVR) (the "Company") today announced that the Company declared a cash dividend of $0.12 per share of common stock for the month of July 2026. The dividend will be paid on August 14, 2026 to stockholders of record at the close of business on July 27, 2026, with an ex-dividend date of July 27, 2026.

Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read.Read full article ↗
fool.com14 Jul 2026

Invesco Healthcare ETF vs VanEck Biotech: Which ETF Will Deliver the Healthiest Returns for 2026?

Invesco S&P 500 Equal Weight Health Care ETF provides broader exposure with 60 holdings compared to the 25 positions in VanEck Biotech ETF VanEck Biotech ETF has a slightly lower expense ratio of 0.35% while Invesco S&P 500 Equal Weight Health Care ETF charges 0.40% Invesco S&P 500 Equal Weight Health Care ETF has experienced a significantly lower five-year maximum drawdown than the biotech fund

Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read.Read full article ↗
fool.com12 Jul 2026

What This Invesco Insider Move Signals With the Stock Up 63%

The transaction involved 26,002 shares withheld to satisfy tax obligations at a value of $702,000 based on the $27.01 per-share price. The disposition reduced the insider's direct common stock position by 17%.

Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read.Read full article ↗
Older updates drop into a lighter feed
prnewswire.com
10 Jul 2026
Invesco Ltd. Announces June 30, 2026 Assets Under Management
Read ↗
fool.com
9 Jul 2026
Invesco Pharmaceuticals ETF vs State Street Biotech ETF: Which Fund Is the Better Buy in 2026?
Read ↗
fool.com
8 Jul 2026
Invesco Pharmaceuticals ETF or First Trust Biotech Fund: Which Drug Maker-Focused Fund Should You Buy in 2026?
Read ↗
businesswire.com
6 Jul 2026
Northern Trust Appointed to Support Invesco's New Index-Tracking Mutual Fund Range
Read ↗
fool.com
4 Jul 2026
State Street Health Care ETF Tops Invesco Pharma on Cost and Size
Read ↗
247wallst.com
3 Jul 2026
Top Invesco Analyst: The AI Trade That “Lifted All Boats” Is Over. Now Profitability Decides Winners As “Capacity Will Catch Up”
Read ↗
Earnings news

IVZ earnings headlines

This section is separated from the general news feed so investors can quickly connect the latest headlines with the structured earnings report.

Beyond the headline

A deeper look for beginners

Generate a short AI read that goes beyond the headlines above, plus a plain-English breakdown of what it could mean going forward.

Continue your IVZ research
Use the stock analysis page for a fuller technical read, open TradingView for charting, or head to Platforms when you are ready to place a trade.